{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:10:19Z","timestamp":1772165419760,"version":"3.50.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T00:00:00Z","timestamp":1594857600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T00:00:00Z","timestamp":1594857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R35GM118337"],"award-info":[{"award-number":["R35GM118337"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R01GM129633"],"award-info":[{"award-number":["R01GM129633"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Co-administration of human ghrelin and growth hormone (GH) reverse immunosuppression in septic aged animals, but the mechanism remains elusive. Here, we hypothesize that ghrelin and GH co-treatment restores the immune response in aged septic rats by inhibiting the production of transforming growth factor-\u03b2 (TGF-\u03b2), an immunoregulatory cytokine, through the vagus nerve.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Male aged Fischer rats (22\u201323-month-old) were made septic by cecal ligation and puncture (CLP) with or without dissecting the vagus nerve (vagotomy). Human ghrelin and GH or vehicle (PBS) were administrated subcutaneously at 5\u2009h post CLP. After 20\u2009h of CLP, serum and spleens were harvested.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Serum TGF-\u03b2 levels were increased in septic aged rats, while ghrelin and GH treatment significantly reduced its levels. Expression of TGF-\u03b2 in the spleen was upregulated after sepsis, while ghrelin and GH treatment significantly inhibited its expression. TNF-\u03b1 and IL-6 levels were significantly reduced after ex vivo LPS stimulation of splenocytes from rats that underwent CLP compared to sham rats; while these levels were significantly higher in splenocytes from ghrelin and GH-treated CLP rats compared to vehicle-treated CLP rats. Ghrelin and GH treatment reduced program death receptor-1 (PD-1) expression, increased human leukocyte antigen-DR (HLA-DR) expression, attenuated lymphopenia, and cleaved caspase-3 levels in the spleen of septic aged rats. Vagotomy diminished the beneficial effects of ghrelin and GH treatment in septic rats. In vitro, the addition of ghrelin, GH, or ghrelin and GH together had no effect on restoring immune response in splenocytes from CLP rats following LPS stimulation, indicating the requirement of the vagus nerve for ghrelin and GH\u2019s effect.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Ghrelin and GH attenuate immunosuppression in aged septic rats through the vagus nerve-dependent inhibition of TGF-\u03b2 production.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s10020-020-00195-x","type":"journal-article","created":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T05:02:46Z","timestamp":1594875766000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Correction of immunosuppression in aged septic rats by human ghrelin and growth hormone through the vagus nerve-dependent inhibition of TGF-\u03b2 production"],"prefix":"10.1186","volume":"26","author":[{"given":"Mian","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monowar","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahendar","family":"Ochani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1557-0394","authenticated-orcid":false,"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,16]]},"reference":[{"key":"195_CR1","doi-asserted-by":"crossref","unstructured":"Abe C, Inoue T. Role of C1 neurons in anti-inflammatory reflex: mediation between afferents and efferents. Neurosci Res. 2018;136:6-12.","DOI":"10.1016\/j.neures.2018.05.001"},{"key":"195_CR2","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/BF03343763","volume":"23","author":"E Arvat","year":"2000","unstructured":"Arvat E, et al. Preliminary evidence that ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans. J Endocrinol Investig. 2000;23:493\u20135.","journal-title":"J Endocrinol Investig"},{"key":"195_CR3","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.488","volume":"5","author":"M Aziz","year":"2014","unstructured":"Aziz M, Jacob A, Wang P. Revisiting caspases in sepsis. Cell Death Dis. 2014;5:e1526.","journal-title":"Cell Death Dis"},{"key":"195_CR4","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/apha.12398","volume":"212","author":"JS Bae","year":"2014","unstructured":"Bae JS, Lee W, Son HN, Lee YM, Kim IS. Anti-transforming growth factor beta-induced protein antibody ameliorates vascular barrier dysfunction and improves survival in sepsis. Acta Physiol. 2014;212:306\u201315.","journal-title":"Acta Physiol"},{"key":"195_CR5","doi-asserted-by":"crossref","first-page":"4545","DOI":"10.4049\/jimmunol.1402550","volume":"194","author":"AP Bally","year":"2015","unstructured":"Bally AP, et al. NF-\u03baB regulates PD-1 expression in macrophages. J Immunol. 2015;194:4545\u201354.","journal-title":"J Immunol"},{"key":"195_CR6","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM200005043421807","volume":"342","author":"GC Blobe","year":"2000","unstructured":"Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor beta in human disease. N Engl J Med. 2000;342:1350\u20138.","journal-title":"N Engl J Med"},{"key":"195_CR7","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bbi.2010.10.008","volume":"25","author":"J Blume","year":"2011","unstructured":"Blume J, Douglas SD, Evans DL. Immune suppression and immune activation in depression. Brain Behav Immun. 2011;25:221\u20139.","journal-title":"Brain Behav Immun"},{"key":"195_CR8","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1001\/jama.2011.1829","volume":"306","author":"JS Boomer","year":"2011","unstructured":"Boomer JS, et al. Immunosuppression in patients who die of sepsis and multiple organ failure. Jama. 2011;306:2594\u2013605.","journal-title":"Jama"},{"key":"195_CR9","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.neuroscience.2004.09.061","volume":"131","author":"MK Borsody","year":"2005","unstructured":"Borsody MK, Weiss JM. The subdiaphragmatic vagus nerves mediate activation of locus coeruleus neurons by peripherally administered microbial substances. Neuroscience. 2005;131:235\u201345.","journal-title":"Neuroscience"},{"key":"195_CR10","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.4049\/jimmunol.178.7.4538","volume":"178","author":"CM Bosio","year":"2007","unstructured":"Bosio CM, Bielefeldt-Ohmann H, Belisle JT. Active suppression of the pulmonary immune response by Francisella tularensis Schu4. J Immunol. 2007;178:4538\u201347.","journal-title":"J Immunol"},{"key":"195_CR11","doi-asserted-by":"crossref","unstructured":"Collden G, Tschop MH, Muller TD. Therapeutic potential of targeting the ghrelin pathway. Int J Mol Sci. 2017;18(4):798.","DOI":"10.3390\/ijms18040798"},{"key":"195_CR12","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1159\/000087109","volume":"12","author":"C Corcoran","year":"2005","unstructured":"Corcoran C, Connor TJ, O'Keane V, Garland MR. The effects of vagus nerve stimulation on pro- and anti-inflammatory cytokines in humans: a preliminary report. Neuroimmunomodulation. 2005;12:307\u20139.","journal-title":"Neuroimmunomodulation"},{"key":"195_CR13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1172\/JCI82224","volume":"126","author":"MJ Delano","year":"2016","unstructured":"Delano MJ, Ward PA. Sepsis-induced immune dysfunction: can immune therapies reduce mortality? J Clin Invest. 2016;126:23\u201331.","journal-title":"J Clin Invest"},{"key":"195_CR14","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1186\/s13054-016-1505-0","volume":"20","author":"AM Drewry","year":"2016","unstructured":"Drewry AM, et al. Comparison of monocyte human leukocyte antigen-DR expression and stimulated tumor necrosis factor alpha production as outcome predictors in severe sepsis: a prospective observational study. Crit Care. 2016;20:334.","journal-title":"Crit Care"},{"key":"195_CR15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1749-6632.2010.05919.x","volume":"1217","author":"BT Fife","year":"2011","unstructured":"Fife BT, Pauken KE. The role of the PD-1 pathway in autoimmunity and peripheral tolerance. Ann N Y Acad Sci. 2011;1217:45\u201359.","journal-title":"Ann N Y Acad Sci"},{"key":"195_CR16","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nri2808","volume":"10","author":"RA Flavell","year":"2010","unstructured":"Flavell RA, Sanjabi S, Wrzesinski SH, Licona-Limon P. The polarization of immune cells in the tumour environment by TGFbeta. Nat Rev Immunol. 2010;10:554\u201367.","journal-title":"Nat Rev Immunol"},{"key":"195_CR17","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1084\/jem.20090847","volume":"206","author":"LM Francisco","year":"2009","unstructured":"Francisco LM, et al. PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J Exp Med. 2009;206:3015\u201329.","journal-title":"J Exp Med"},{"key":"195_CR18","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1053\/j.gastro.2006.01.041","volume":"130","author":"E Gonzalez-Rey","year":"2006","unstructured":"Gonzalez-Rey E, Chorny A, Delgado M. Therapeutic action of ghrelin in a mouse model of colitis. Gastroenterology. 2006;130:1707\u201320.","journal-title":"Gastroenterology"},{"key":"195_CR19","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0163-7258(03)00035-4","volume":"98","author":"R Govinden","year":"2003","unstructured":"Govinden R, Bhoola KD. Genealogy, expression, and cellular function of transforming growth factor-beta. Pharmacol Ther. 2003;98:257\u201365.","journal-title":"Pharmacol Ther"},{"key":"195_CR20","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000007404","volume":"96","author":"M Hensel","year":"2017","unstructured":"Hensel M, et al. Peripheral monocytosis as a predictive factor for adverse outcome in the emergency department: survey based on a register study. Medicine (Baltimore). 2017;96:e7404.","journal-title":"Medicine (Baltimore)"},{"key":"195_CR21","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ccc.2013.03.016","volume":"29","author":"HJ Hepper","year":"2013","unstructured":"Hepper HJ, Sieber C, Walger P, Bahrmann P, Singler K. Infections in the elderly. Crit Care Clin. 2013;29:757\u201374.","journal-title":"Crit Care Clin"},{"key":"195_CR22","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMra021333","volume":"348","author":"RS Hotchkiss","year":"2003","unstructured":"Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med. 2003;348:138\u201350.","journal-title":"N Engl J Med"},{"key":"195_CR23","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nri3552","volume":"13","author":"RS Hotchkiss","year":"2013","unstructured":"Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol. 2013;13:862\u201374.","journal-title":"Nat Rev Immunol"},{"key":"195_CR24","doi-asserted-by":"crossref","first-page":"6952","DOI":"10.4049\/jimmunol.166.11.6952","volume":"166","author":"RS Hotchkiss","year":"2001","unstructured":"Hotchkiss RS, et al. Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans. J Immunol. 2001;166:6952\u201363.","journal-title":"J Immunol"},{"key":"195_CR25","doi-asserted-by":"crossref","first-page":"R130","DOI":"10.1186\/cc13941","volume":"18","author":"S Inoue","year":"2014","unstructured":"Inoue S, et al. Persistent inflammation and T cell exhaustion in severe sepsis in the elderly. Crit Care. 2014;18:R130.","journal-title":"Crit Care"},{"key":"195_CR26","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1172\/JCI83658","volume":"126","author":"T Inoue","year":"2016","unstructured":"Inoue T, et al. Vagus nerve stimulation mediates protection from kidney ischemia-reperfusion injury through alpha7nAChR+ splenocytes. J Clin Invest. 2016;126:1939\u201352.","journal-title":"J Clin Invest"},{"key":"195_CR27","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","volume":"26","author":"ME Keir","year":"2008","unstructured":"Keir ME, Butte MJ, Freeman GJ, Sharpe AH. PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol. 2008;26:677\u2013704.","journal-title":"Annu Rev Immunol"},{"key":"195_CR28","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1152\/physrev.00012.2004","volume":"85","author":"M Kojima","year":"2005","unstructured":"Kojima M, Kangawa K. Ghrelin: structure and function. Physiol Rev. 2005;85:495\u2013522.","journal-title":"Physiol Rev"},{"key":"195_CR29","first-page":"47","volume":"35","author":"KY Lee","year":"2002","unstructured":"Lee KY, Bae SC. TGF-beta-dependent cell growth arrest and apoptosis. J Biochem Mol Biol. 2002;35:47\u201353.","journal-title":"J Biochem Mol Biol"},{"key":"195_CR30","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jcrc.2014.04.018","volume":"29","author":"A Lekkou","year":"2014","unstructured":"Lekkou A, Mouzaki A, Siagris D, Ravani I, Gogos CA. Serum lipid profile, cytokine production, and clinical outcome in patients with severe sepsis. J Crit Care. 2014;29:723\u20137.","journal-title":"J Crit Care"},{"key":"195_CR31","doi-asserted-by":"crossref","first-page":"520","DOI":"10.7326\/0003-4819-125-6-199609150-00034","volume":"125","author":"C Marie","year":"1996","unstructured":"Marie C, Cavaillon JM, Losser MR. Elevated levels of circulating transforming growth factor-beta 1 in patients with the sepsis syndrome. Ann Intern Med. 1996;125:520\u20131.","journal-title":"Ann Intern Med"},{"key":"195_CR32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/01.CCM.0000194535.82812.BA","volume":"34","author":"GS Martin","year":"2006","unstructured":"Martin GS, Mannino DM, Moss M. The effect of age on the development and outcome of adult sepsis. Crit Care Med. 2006;34:15\u201321.","journal-title":"Crit Care Med"},{"key":"195_CR33","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1165\/rcmb.2014-0226TR","volume":"53","author":"T Narula","year":"2015","unstructured":"Narula T, deBoisblanc BP. Ghrelin in Critical Illness. Am J Respir Cell Mol Biol. 2015;53:437\u201342.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"Suppl 7","key":"195_CR34","doi-asserted-by":"crossref","first-page":"S504","DOI":"10.1086\/432007","volume":"41","author":"SM Opal","year":"2005","unstructured":"Opal SM, Girard TD, Ely EW. The immunopathogenesis of sepsis in elderly patients. Clin Infect Dis. 2005;41(Suppl 7):S504\u201312.","journal-title":"Clin Infect Dis"},{"key":"195_CR35","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.clim.2013.03.001","volume":"147","author":"Y Ota","year":"2013","unstructured":"Ota Y, et al. Ghrelin attenuates collagen production in lesional fibroblasts from patients with systemic sclerosis. Clin Immunol. 2013;147:71\u20138.","journal-title":"Clin Immunol"},{"key":"195_CR36","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1074\/jbc.M008170200","volume":"276","author":"A Pellacani","year":"2001","unstructured":"Pellacani A, et al. Down-regulation of high mobility group-I(Y) protein contributes to the inhibition of nitric-oxide synthase 2 by transforming growth factor-beta1. J Biol Chem. 2001;276:1653\u20139.","journal-title":"J Biol Chem"},{"key":"195_CR37","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nri3818","volume":"15","author":"PA Roche","year":"2015","unstructured":"Roche PA, Furuta K. The ins and outs of MHC class II-mediated antigen processing and presentation. Nat Rev Immunol. 2015;15:203\u201316.","journal-title":"Nat Rev Immunol"},{"key":"195_CR38","doi-asserted-by":"crossref","unstructured":"Roquilly A, et al. Local modulation of antigen-presenting cell development after resolution of pneumonia induces long-term susceptibility to secondary infections. Immunity. 2017;47:135\u2013147.e5.","DOI":"10.1016\/j.immuni.2017.06.021"},{"key":"195_CR39","first-page":"728","volume":"4","author":"M Santarpia","year":"2015","unstructured":"Santarpia M, et al. Programmed cell death protein-1\/programmed cell death ligand-1 pathway inhibition and predictive biomarkers: understanding transforming growth factor-beta role. Transl Lung Cancer Res. 2015;4:728\u201342.","journal-title":"Transl Lung Cancer Res"},{"key":"195_CR40","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/ni1309","volume":"7","author":"NV Serbina","year":"2006","unstructured":"Serbina NV, Pamer EG. Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat Immunol. 2006;7:311\u20137.","journal-title":"Nat Immunol"},{"key":"195_CR41","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). Jama. 2016;315:801\u201310.","journal-title":"Jama"},{"key":"195_CR42","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1189\/jlb.0708415","volume":"85","author":"AW Taylor","year":"2009","unstructured":"Taylor AW. Review of the activation of TGF-beta in immunity. J Leukoc Biol. 2009;85:29\u201333.","journal-title":"J Leukoc Biol"},{"key":"195_CR43","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1084\/jem.20051760","volume":"202","author":"KJ Tracey","year":"2005","unstructured":"Tracey KJ. Fat meets the cholinergic antiinflammatory pathway. J Exp Med. 2005;202:1017\u201321.","journal-title":"J Exp Med"},{"key":"195_CR44","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1172\/JCI30555","volume":"117","author":"KJ Tracey","year":"2007","unstructured":"Tracey KJ. Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest. 2007;117:289\u201396.","journal-title":"J Clin Invest"},{"key":"195_CR45","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/infdis\/jis383","volume":"206","author":"J Unsinger","year":"2012","unstructured":"Unsinger J, et al. Interleukin-7 ameliorates immune dysfunction and improves survival in a 2-hit model of fungal sepsis. J Infect Dis. 2012;206:606\u201316.","journal-title":"J Infect Dis"},{"key":"195_CR46","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2017.36","volume":"17","author":"T van der Poll","year":"2017","unstructured":"van der Poll T, van de Veerdonk FL, Scicluna BP, Netea MG. The immunopathology of sepsis and potential therapeutic targets. Nat Rev Immunol. 2017;17:407\u201320.","journal-title":"Nat Rev Immunol"},{"key":"195_CR47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128341","volume":"10","author":"D Vieira da Silva Pellegrina","year":"2015","unstructured":"Vieira da Silva Pellegrina D, et al. Septic shock in advanced age: Transcriptome analysis reveals altered molecular signatures in neutrophil granulocytes. PLoS One. 2015;10:e0128341.","journal-title":"PLoS One"},{"key":"195_CR48","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1128\/IAI.05534-11","volume":"80","author":"TA Weehuizen","year":"2012","unstructured":"Weehuizen TA, et al. Expression and function of transforming growth factor beta in melioidosis. Infect Immun. 2012;80:1853\u20137.","journal-title":"Infect Immun"},{"key":"195_CR49","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.cyto.2010.01.003","volume":"50","author":"M White","year":"2010","unstructured":"White M, et al. Transforming growth factor beta-1 and interleukin-17 gene transcription in peripheral blood mononuclear cells and the human response to infection. Cytokine. 2010;50:322\u20137.","journal-title":"Cytokine"},{"key":"195_CR50","doi-asserted-by":"crossref","first-page":"5184","DOI":"10.1210\/en.2003-1059","volume":"144","author":"DL Williams","year":"2003","unstructured":"Williams DL, Grill HJ, Cummings DE, Kaplan JM. Vagotomy dissociates short- and long-term controls of circulating ghrelin. Endocrinology. 2003;144:5184\u20137.","journal-title":"Endocrinology"},{"key":"195_CR51","doi-asserted-by":"crossref","first-page":"5262","DOI":"10.1158\/1078-0432.CCR-07-1157","volume":"13","author":"SH Wrzesinski","year":"2007","unstructured":"Wrzesinski SH, Wan YY, Flavell RA. Transforming growth factor-beta and the immune response: implications for anticancer therapy. Clin Cancer Res. 2007;13:5262\u201370.","journal-title":"Clin Cancer Res"},{"key":"195_CR52","doi-asserted-by":"crossref","unstructured":"Wu HP, et al. Plasma transforming growth factor-beta1 level in patients with severe community-acquired pneumonia and association with disease severity. J Formos Med Assoc. 2009b;108:20\u20137.","DOI":"10.1016\/S0929-6646(09)60028-0"},{"key":"195_CR53","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/01.sla.0000118561.54919.61","volume":"239","author":"JT Wu","year":"2004","unstructured":"Wu JT, Kral JG. Ghrelin: integrative neuroendocrine peptide in health and disease. Ann Surg. 2004;239:464\u201374.","journal-title":"Ann Surg"},{"key":"195_CR54","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1164\/rccm.200604-511OC","volume":"176","author":"R Wu","year":"2007","unstructured":"Wu R, et al. Ghrelin attenuates sepsis-induced acute lung injury and mortality in rats. Am J Respir Crit Care Med. 2007a;176:805\u201313.","journal-title":"Am J Respir Crit Care Med"},{"key":"195_CR55","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/01.sla.0000251614.42290.ed","volume":"245","author":"R Wu","year":"2007","unstructured":"Wu R, et al. Ghrelin down-regulates proinflammatory cytokines in sepsis through activation of the vagus nerve. Ann Surg. 2007b;245:480\u20136.","journal-title":"Ann Surg"},{"key":"195_CR56","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/SLA.0b013e3181ad85d6","volume":"250","author":"R Wu","year":"2009","unstructured":"Wu R, et al. Ghrelin hyporesponsiveness contributes to age-related hyperinflammation in septic shock. Ann Surg. 2009a;250:126\u201333.","journal-title":"Ann Surg"},{"key":"195_CR57","doi-asserted-by":"crossref","unstructured":"Yang WL, et al. Combined administration of human ghrelin and human growth hormone attenuates organ injury and improves survival in aged septic rats. Mol Med. 2016;22:124\u201335.","DOI":"10.2119\/molmed.2015.00255"},{"key":"195_CR58","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/jb\/mvq043","volume":"147","author":"A Yoshimura","year":"2010","unstructured":"Yoshimura A, Wakabayashi Y, Mori T. Cellular and molecular basis for the regulation of inflammation by TGF-beta. J Biochem. 2010;147:781\u201392.","journal-title":"J Biochem"},{"key":"195_CR59","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jad.2017.12.099","volume":"234","author":"HX Zhang","year":"2018","unstructured":"Zhang HX, et al. Difference in proinflammatory cytokines produced by monocytes between patients with major depressive disorder and healthy controls. J Affect Disord. 2018;234:305\u201310.","journal-title":"J Affect Disord"},{"key":"195_CR60","first-page":"929","volume":"25","author":"M Zhou","year":"2010","unstructured":"Zhou M, Wu R, Dong W, Leong J, Wang P. Accelerated apoptosis contributes to aging-related hyperinflammation in endotoxemia. Int J Mol Med. 2010;25:929\u201335.","journal-title":"Int J Mol Med"},{"key":"195_CR61","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1016\/j.bbadis.2017.01.014","volume":"1863","author":"M Zhou","year":"2017","unstructured":"Zhou M, Yang WL, Aziz M, Ma G, Wang P. Therapeutic effect of human ghrelin and growth hormone: attenuation of immunosuppression in septic aged rats. Biochim Biophys Acta. 2017;1863:2584\u201393.","journal-title":"Biochim Biophys Acta"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-020-00195-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-020-00195-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-020-00195-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T20:09:31Z","timestamp":1626379771000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.1186\/s10020-020-00195-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,16]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["195"],"URL":"https:\/\/doi.org\/10.1186\/s10020-020-00195-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-26491\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-26491\/v1","asserted-by":"object"}]},"ISSN":["1076-1551","1528-3658"],"issn-type":[{"value":"1076-1551","type":"print"},{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,16]]},"assertion":[{"value":"29 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experiments were performed in accordance with the NIH guidelines for the use of experimental animals, and the study was approved by the Institutional Animal Care and Use Committee (IACUC) of the Feinstein Institutes for Medical Research.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Authors agreed to this publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"71"}}